Biomerica, Inc. (BMRA) rose 21.53 percent to $3.67, gaining $0.65 on Thursday, after the UAE Ministry of Health and Prevention approved its Fortel Ulcer Test for home use. The rapid 10-minute diagnostic detects antibodies to Helicobacter pylori, a bacterium linked to peptic ulcers, chronic digestive pain, and up to 80 percent of gastric cancer cases.
The stock opened at $4.19 and traded between $3.55 and $4.60, with 37.67 million shares exchanged, compared with an average daily volume of 52,012 on the Nasdaq.
Biomerica's 52-week range is $2.08 to $10.16.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.